Phage Therapy: Beyond Antibacterial Action
Until recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on p...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00146/full |
id |
doaj-7f5687ddec264ea9897457ca9b3395f7 |
---|---|
record_format |
Article |
spelling |
doaj-7f5687ddec264ea9897457ca9b3395f72020-11-24T21:10:28ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2018-05-01510.3389/fmed.2018.00146369809Phage Therapy: Beyond Antibacterial ActionAndrzej Górski0Andrzej Górski1Andrzej Górski2Ewa Jończyk-Matysiak3Ryszard Międzybrodzki4Ryszard Międzybrodzki5Ryszard Międzybrodzki6Beata Weber-Dąbrowska7Beata Weber-Dąbrowska8Marzanna Łusiak-Szelachowska9Natalia Bagińska10Jan Borysowski11Małgorzata B. Łobocka12Małgorzata B. Łobocka13Alicja Węgrzyn14Grzegorz Węgrzyn15Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandPhage Therapy Unit, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, PolandDepartment of Clinical Immunology, Transplantation Institute, Medical University of Warsaw, Warsaw, PolandInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, PolandAutonomous Department of Microbial Biology, Faculty of Agriculture and Biology, Warsaw University of Life Sciences, Warsaw, PolandLaboratory of Molecular Biology, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Gdańsk, PolandDepartment of Molecular Biology, University of Gdańsk, Gdańsk, PolandUntil recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein.https://www.frontiersin.org/article/10.3389/fmed.2018.00146/fullphagephage therapyimmunomodulationinflammationprophage induction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Andrzej Górski Andrzej Górski Andrzej Górski Ewa Jończyk-Matysiak Ryszard Międzybrodzki Ryszard Międzybrodzki Ryszard Międzybrodzki Beata Weber-Dąbrowska Beata Weber-Dąbrowska Marzanna Łusiak-Szelachowska Natalia Bagińska Jan Borysowski Małgorzata B. Łobocka Małgorzata B. Łobocka Alicja Węgrzyn Grzegorz Węgrzyn |
spellingShingle |
Andrzej Górski Andrzej Górski Andrzej Górski Ewa Jończyk-Matysiak Ryszard Międzybrodzki Ryszard Międzybrodzki Ryszard Międzybrodzki Beata Weber-Dąbrowska Beata Weber-Dąbrowska Marzanna Łusiak-Szelachowska Natalia Bagińska Jan Borysowski Małgorzata B. Łobocka Małgorzata B. Łobocka Alicja Węgrzyn Grzegorz Węgrzyn Phage Therapy: Beyond Antibacterial Action Frontiers in Medicine phage phage therapy immunomodulation inflammation prophage induction |
author_facet |
Andrzej Górski Andrzej Górski Andrzej Górski Ewa Jończyk-Matysiak Ryszard Międzybrodzki Ryszard Międzybrodzki Ryszard Międzybrodzki Beata Weber-Dąbrowska Beata Weber-Dąbrowska Marzanna Łusiak-Szelachowska Natalia Bagińska Jan Borysowski Małgorzata B. Łobocka Małgorzata B. Łobocka Alicja Węgrzyn Grzegorz Węgrzyn |
author_sort |
Andrzej Górski |
title |
Phage Therapy: Beyond Antibacterial Action |
title_short |
Phage Therapy: Beyond Antibacterial Action |
title_full |
Phage Therapy: Beyond Antibacterial Action |
title_fullStr |
Phage Therapy: Beyond Antibacterial Action |
title_full_unstemmed |
Phage Therapy: Beyond Antibacterial Action |
title_sort |
phage therapy: beyond antibacterial action |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2018-05-01 |
description |
Until recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein. |
topic |
phage phage therapy immunomodulation inflammation prophage induction |
url |
https://www.frontiersin.org/article/10.3389/fmed.2018.00146/full |
work_keys_str_mv |
AT andrzejgorski phagetherapybeyondantibacterialaction AT andrzejgorski phagetherapybeyondantibacterialaction AT andrzejgorski phagetherapybeyondantibacterialaction AT ewajonczykmatysiak phagetherapybeyondantibacterialaction AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction AT ryszardmiedzybrodzki phagetherapybeyondantibacterialaction AT beataweberdabrowska phagetherapybeyondantibacterialaction AT beataweberdabrowska phagetherapybeyondantibacterialaction AT marzannałusiakszelachowska phagetherapybeyondantibacterialaction AT nataliabaginska phagetherapybeyondantibacterialaction AT janborysowski phagetherapybeyondantibacterialaction AT małgorzatabłobocka phagetherapybeyondantibacterialaction AT małgorzatabłobocka phagetherapybeyondantibacterialaction AT alicjawegrzyn phagetherapybeyondantibacterialaction AT grzegorzwegrzyn phagetherapybeyondantibacterialaction |
_version_ |
1716756458100490240 |